Myriad Genetics Inc. (NASDAQ:MYGN) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are down 2.81%.
Myriad Genetics Inc. Earnings Cheat Sheet
Results: Adjusted Earnings Per Share increased 55.88% to $0.53 in the quarter versus EPS of $0.34 in the year-earlier quarter.
Revenue: Rose 30.93% to $174.1 million from the year-earlier quarter.
Actual vs. Wall St. Expectations: Myriad Genetics Inc. reported adjusted EPS income of $0.53 per share. By that measure, the company beat the mean analyst estimate of $0.44. It beat the average revenue estimate of $159.87 million.
Quoting Management: “Myriad had an exceptional fourth quarter and delivered strong financial results in fiscal 2013 by successfully growing our existing businesses, and I am proud of the entire Myriad team,” said Peter D. Meldrum, President and Chief Executive Officer of Myriad. “We are investing for future growth and expect to launch three exciting new tests in fiscal 2014, including myRisk Hereditary Cancer, myPath Melanoma, and myPlan Lung Cancer, all of which address significant unmet clinical needs. Additionally, we are engaging in several external collaborations, particularly in the area of companion diagnostics and personalized medicine that have the potential to deliver long-term value to our shareholders.”
Key Stats (on next page)…
Revenue increased 11.27% from $156.47 million in the previous quarter. EPS increased 15.22% from $0.46 in the previous quarter.
Looking Forward: Analysts have a more positive outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has risen from a profit of $0.42 to a profit $0.43. For the current year, the average estimate has moved up from a profit of $1.66 to a profit of $1.67 over the last ninety days.
Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.
(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)